.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Accenture
Medtronic
Covington
Mallinckrodt
Citi
Moodys
US Army
AstraZeneca
McKesson
Cantor Fitzgerald

Generated: December 14, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 088127

« Back to Dashboard

NDA 088127 describes HYDROFLUMETHIAZIDE AND RESERPINE, which is a drug marketed by Usl Pharma and Watson Labs and is included in three NDAs. Additional details are available on the HYDROFLUMETHIAZIDE AND RESERPINE profile page.

The generic ingredient in HYDROFLUMETHIAZIDE AND RESERPINE is hydroflumethiazide; reserpine. There are two drug master file entries for this compound. Additional details are available on the hydroflumethiazide; reserpine profile page.

Summary for 088127

Tradename:1
Applicant:1
Ingredient:1
Patents:0
Formulation / Manufacturing:see details

Summary for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength25MG;0.125MG
Approval Date:Mar 22, 1983TE:RLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Baxter
McKesson
Mallinckrodt
Chubb
QuintilesIMS
Julphar
Medtronic
Moodys
Novartis
Queensland Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot